10. Fentora - Top 10 Warnings and Recalls

Drug: Fentora

2006 sales: $370 million

Manufacturer: Cephalon

Safety concern: Warning; improper dosing leading to death

Related Articles:
> New warning for off-label Fentora. Report
> Red flags raised on Fentora misuse. Report
> FDA approves Fentora for cancer pain. Report
> Cephalon shares jump on Fentora decision. Report
> Cephalon takes heat for off-label narcotic promotion. Report

10. Fentora - Top 10 Warnings and Recalls
Read more on

Suggested Articles

fighting
Marketing

Keytruda's bladder cancer gene therapy rival wins in phase 3

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

by Angus Liu
Novartis headquarters
Pharma

FDA greenlights generics of Novartis' $3B MS star Gilenya

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

by Arlene Weintraub
armwrestle
Pharma

Gilead runs into pushback on HIV drug patent extension

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.

by Eric Sagonowsky